ixazomib,daratumumab
takeda,janssen
['mmsm']
#asco22 oral session #mmsm ifm-2018-02 ixa+dara phase ii study note only 60% got previous velcade, majority had one line aes: some significant avoiding steroids does not necessarily mean better outcomes and less aes 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities. No COI